SCHEMBL11277519

SCHEMBL11277519

OP(O)OCCCc1ccccc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 1/20 0.55
LMNA P02545 1/20 0.52
SMN1; SMN2 Q16637 2/20 0.50
NPC1 O15118 1/20 0.50
RECQL P46063 1/20 0.50
RAB9A P51151 1/20 0.50
SIGMAR1 Q99720 3/20 0.48
FFAR1 O14842 1/20 0.46
DRD2 P14416 1/20 0.46
DRD4 P21917 1/20 0.46
DRD3 P35462 1/20 0.46
HDAC3 O15379 1/20 0.45
MAPK1 P28482 1/20 0.45
ADRA1A P35348 1/20 0.45
HDAC4 P56524 1/20 0.45
SLC6A3 Q01959 1/20 0.45
HDAC1 Q13547 1/20 0.45
HDAC7 Q8WUI4 1/20 0.45
HDAC2 Q92769 1/20 0.45
HDAC10 Q969S8 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7341046 0.94 IDO1 (0.48) IDO1LMNASMN1; SMN2NPC1RECQL
SCHEMBL11880603 0.92 SIGMAR1 (0.50) IDO1LMNASIGMAR1FFAR1HDAC1
SCHEMBL6743777 0.92 SIGMAR1 (0.50) IDO1LMNASIGMAR1FFAR1HDAC1
SCHEMBL6462217 0.92 SIGMAR1 (0.50) IDO1LMNASIGMAR1FFAR1HDAC1
SCHEMBL29036387 0.92 SIGMAR1 (0.50) IDO1LMNASIGMAR1FFAR1HDAC1
SCHEMBL7107595 0.92 SIGMAR1 (0.50) IDO1LMNASIGMAR1FFAR1HDAC1
SCHEMBL6561009 0.92 SIGMAR1 (0.50) IDO1LMNASIGMAR1FFAR1HDAC1
SCHEMBL17360726 0.89 IDO1 (0.57) IDO1LMNASMN1; SMN2NPC1RECQL
SCHEMBL2129084 0.87 TDP1 (0.46) IDO1LMNASMN1; SMN2NPC1RAB9A
SCHEMBL23928752 0.84 IDO1 (0.57) IDO1LMNASMN1; SMN2NPC1RECQL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2766376-B1 METHOD FOR THE ESTERIFICATION OF P-O COMPONENTS STRAITMARK HOLDING AG (CH) 2015-12-30 EP claimed
EP-2766376-A1 METHOD FOR THE ESTERIFICATION OF P-O COMPONENTS Straitmark Holding AG (CH) 2014-08-20 EP claimed
WO-2013053939-A1 METHOD FOR THE ESTERIFICATION OF P-O COMPONENTS STRAITMARK HOLDING AG (CH) 2013-04-18 WO claimed
EP-2581378-A1 Method for the esterification of P-O components Straitmark Holding AG (CH) 2013-04-17 EP claimed
CN-115997016-A Composition comprising nucleic acid nanoparticles having modular functional groups 西克斯福德生物科学有限公司 2023-04-21 CN disclosed
EP-2766376-B1 METHOD FOR THE ESTERIFICATION OF P-O COMPONENTS STRAITMARK HOLDING AG (CH) 2015-12-30 EP disclosed
EP-2766376-A1 METHOD FOR THE ESTERIFICATION OF P-O COMPONENTS Straitmark Holding AG (CH) 2014-08-20 EP disclosed
WO-2013053939-A1 METHOD FOR THE ESTERIFICATION OF P-O COMPONENTS STRAITMARK HOLDING AG (CH) 2013-04-18 WO disclosed
EP-2581378-A1 Method for the esterification of P-O components Straitmark Holding AG (CH) 2013-04-17 EP disclosed
CN-1230889-A NAALADase compositions and methods for treating glutamate abnormalities and for producing neuronal activity in animals GUILFORD PHARM INC (US) 1999-10-06 CN disclosed
CN-1221346-A Methods of cancer treatment using NAALADase inhibitors GUILFORD PHARM INC (US) 1999-06-30 CN disclosed
EP-0013382-B1 PROCESS FOR THE PREPARATION OF M-AMINO-PHENOLS BASF Aktiengesellschaft (DE) 1982-12-15 EP disclosed
EP-0013382-A1 Process for the preparation of m-amino-phenols BASF Aktiengesellschaft (DE) 1980-07-23 EP disclosed
US-4067903-A Manufacture of arylamines BASF AKTIENGESELLSCHAFT (DT) 1978-01-10 US disclosed